Clinical Trial Update: BHV-7000 Open-Label Extension Bipolar Mania Study [Phase 2]

View source ↗

Summary

Biohaven's BHV-7000 Phase 2 open-label extension study for bipolar mania has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bipolar Disorder

Drugs mentioned

• BHV-7000

Snippet

Sponsor: Biohaven Therapeutics Ltd. | Conditions: Bipolar Disorder | Phase 2 | Status: TERMINATED